| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 2e-06 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |